Understand the platform and the buyer's thesis
Ask what the platform is intended to become. A sponsor may seek geographic density, access to new hospitals and ASCs, broader recruiting reach, central billing, or the ability to combine physician groups. The thesis matters because it predicts where management attention and capital may go. Request an explanation of the platform's current footprint, operating structure, acquisitions, integration plans, and financial reporting approach. Distinguish completed transactions from announced plans and proposed targets.
PE-backed anesthesia consolidation has developed through platform acquisitions, add-on practices, and sponsor exits. That history offers examples of how scale can support centralized administration and broader contracting, while also showing that integration, use, staffing supply, and facility relationships remain consequential. Past platform outcomes do not establish the value of a new offer. A sponsor's prior multiple or successful exit may reflect market conditions, growth, debt, as well as leadership and assets that differ from the group being asked to sell. Ask for directly relevant experience: how similar groups were integrated, how physician governance evolved, what happened to local contracts, and what obligations owners faced when the platform changed hands.
Clarify which entity is buying the practice assets or equity, which entity employs clinicians, and which entity holds facility agreements. In some structures, a management company provides nonclinical services while professional entities remain separately organized. Review the management services agreement, fee formula, service scope, term, termination rights, and control of billing, staffing support, as well as technology and administrative functions. Understand how these entities interact before assuming that the physician owners will retain control over clinical operations or contract decisions.
Translate enterprise value into cash and retained risk
Enterprise value is a measure of the operating business before allocating value among debt and equity holders. It is not the amount each partner receives. A transaction bridge generally begins with agreed enterprise value, adjusts for debt and debt-like items, adds or subtracts working capital against a defined target, accounts for transaction expenses and other agreed items, and arrives at equity value. Then owner-specific allocations, taxes, escrow, notes, as well as rollover and other holdbacks affect cash received. Ask the buyer for the complete funds-flow model and the definitions behind every line.
Working capital can be contentious in a physician practice because collections arrive after services, payroll may be paid before facility receipts, and accounts receivable may include denials, old balances, or disputed claims. The purchase agreement should define included assets and liabilities, the calculation method, the reference period, and the process for resolving disagreements. Review treatment of cash, accrued compensation, vacation, bonuses, taxes, payer recoupments, and outstanding claims. Have an accounting adviser reproduce the calculation using the group's records. A vague target can transfer value from sellers through an adjustment that was difficult to see in the headline price.
Consider how earnings are being valued. A buyer may apply a multiple to normalized EBITDA, but the accepted EBITDA is negotiated and may reflect a partner compensation reset. Owners who historically received distributions alongside relatively low wages may see a proposed reduction for market replacement compensation. If a buyer assumes it must hire management or replace unpaid partner labor, it may also add costs. Ask for the buyer's specific EBITDA bridge, each accepted and rejected adjustment, and compare it with an independent quality-of-earnings review. A higher multiple applied to a disputed earnings base may be less valuable than a lower multiple applied to a supportable one.
Illustrative example: suppose an offer states enterprise value of $40 million and the closing bridge deducts $6 million of debt and debt-like items, $1 million of expenses, and a $2 million working-capital shortfall. The resulting equity value before taxes and owner allocation would be $31 million. If $8 million of seller proceeds is reinvested as rollover and $2 million is held in escrow, cash at closing would be lower still. These figures are illustrative only and show why owners need the full bridge; they do not imply a market valuation or predict a transaction result.
Examine each form of consideration
Cash at closing is usually the most certain part, although it remains subject to closing conditions and the final adjustment process. Escrow may secure indemnity claims or other obligations. Determine the amount, duration, claim procedure, release schedule, and whether escrow is shared or several among sellers. Ask whether any indemnity is capped, subject to a basket, or backed by insurance. Review who bears liability for pre-close billing, employment, tax, as well as compliance and contract matters, and whether an individual owner can be responsible for another person's conduct.
A seller note is debt owed by the buyer or an affiliate under negotiated terms. Read interest, maturity, payment priority, security, subordination, default remedies, and the effect of a later sale or refinancing. Ask whether payments may be blocked by senior lenders or cash-flow covenants. Assess the credit of the actual obligor instead of assuming that the sponsor itself guarantees repayment. A note can increase nominal consideration while leaving the seller exposed to the same platform risks that motivated the sale.
An earnout depends on a defined future result. It may use collections, EBITDA, contract retention, or another measure, but the seller may not control the accounting, staffing, pricing, payer strategy, or cost allocations that drive it. Define the metric, accounting policies, access to records, operating commitments, dispute resolution, and treatment of acquisitions or shared expenses. Determine whether an owner must remain employed to receive payment and what happens after termination, disability, or a facility contract change. Run a case where the earnout pays nothing and decide whether the remaining guaranteed value is acceptable.
Rollover equity is not cash deferred on a fixed schedule. It is a continuing ownership investment exposed to business performance, debt, fees, dilution, as well as governance and exit timing. Ask precisely which legal entity issues the equity and whether the investment is in the parent platform, a subsidiary, or a transaction-specific vehicle. Obtain the capitalization table before and after closing, the governing agreement, securities description, distribution waterfall, and any investor presentation referenced in the offer. If the sponsor describes a percentage ownership, determine the denominator and whether that percentage is fully diluted.
Read the rollover economics, not only the target return
Rollover holders may own a different class of security from the sponsor. The sponsor's preferred return, management incentive pool, transaction fees, and other preferences can affect how proceeds are allocated at exit. Request a distribution waterfall model at several sale values and debt levels. Trace how much would be paid to each class before common equity receives anything. Determine whether a preferred return compounds, whether fees accrue, and whether management equity is granted before or after the owners' percentage is calculated.
Ask about additional capital needs. The platform may fund acquisitions, technology, recruiting, or working capital with debt or equity. Review whether rollover holders can be required to contribute capital, whether failure to contribute causes dilution, and who decides when funds are raised. Find out whether the sponsor can issue senior securities, amend rights, or incur debt without minority approval. Understand the limits on transfer, pledge, or sale of the rollover. A paper ownership interest with no practical transfer or liquidity path can remain illiquid for a long period.
Information and governance rights affect the owner's ability to assess that investment. Determine what financial statements, budgets, tax materials, and operating reports are delivered and how often. Identify board representation, observer rights, reserved matters, conflict procedures, and the threshold for approving a sale. Minority holders may have limited influence over when the sponsor exits, which buyer is chosen, or how the platform deploys capital. Examine drag-along requirements, tag rights, preemptive rights, and protections against a sale on terms that differ among classes.
Model the rollover on a net basis. Start with the amount reinvested. Then subtract debt repayment and transaction costs. Apply the distribution waterfall and dilution before estimating after-tax proceeds. For an illustrative $10 million rollover, compare 3-year and 5-year holds with 10% and 20% dilution assumptions. Include a weak outcome in which growth slows or a major facility agreement is lost, as well as a case where the platform performs well. Do not treat a sponsor's target return as a promised return. Clearly label every assumed exit value, multiple, debt balance, dilution rate, and time horizon as illustrative. Run at least three exit cases in the sensitivity table. For example, compare a 3-year hold with a 5-year hold, 10% dilution with 20%, and two debt balances. Vary the sale multiple separately so partners can see which assumption drives their proceeds.
Test the operating plan against anesthesia realities
The buyer's plan needs qualified clinicians at the sites where contracts require coverage. Review current vacancies, turnover, locum reliance, call arrangements, as well as compensation and recruiting pipeline. Ask who will manage recruitment, credentialing, as well as scheduling and retention after closing. A centralized team may improve coordination, but it cannot instantly solve a regional shortage or make a facility contract flexible. Determine whether the sponsor's budget assumes a care team mix that the facility, workforce, payer rules, and applicable requirements will support.
Explore the relationship between professional collections and facility support. If hospital stipends or subsidies cover a gap between professional revenue and required coverage, ask whether those agreements are included in the platform's forecast and on what terms. A sponsor may expect to renegotiate a subsidy, change staffing, or add service obligations. Each can alter earnings. Confirm which party controls discussions with the hospital and whether physician leaders retain a meaningful voice. Review ASC contracts separately, exclusivity, ownership relationships, as well as assignment and termination terms.
Payer projections should reflect actual unit economics. For material contracts, compare ASA base and time unit rules, anesthesia conversion factors, modifiers, collection performance, and denial behavior. If the forecast assumes improved rates or collections, identify the contractual event or operational change that could produce them. Likewise, examine the payer mix and exposure to out-of-network claims. Where No Surprises Act processes and IDR affect the group, ask how the platform will manage eligibility, documentation, as well as submissions and revenue recognition. Unresolved disputes should not be presented as certain platform earnings.
Look at acquisition integration costs and responsibilities. Who migrates billing records, reconciles historical A/R, standardizes provider agreements, and aligns compensation? How are local facility concerns handled if central policies change? Request examples of transition plans from comparable practices and compare their stated milestones with actual results. If the platform is still acquiring, determine whether management capacity is sufficient to integrate the existing group while pursuing additional deals. Growth can increase value, but poor integration can distract from the operating base that supports current cash flow.
Align employment, as well as control and personal outcomes
Review employment agreements independently from sale documents. Clarify salary, productivity measures, call, schedule, site assignment, leadership duties, benefits, termination rights, restrictive covenants, and professional liability coverage. If physician compensation changes after closing, understand the formula and who may revise it. A partner's sale proceeds and future compensation are separate economic arrangements; one should not be used to obscure a weakness in the other.
Define clinical and administrative authority. Ask which decisions belong to physicians, the professional entity, facility leaders, and the management company. Review budget approval, hiring, contracting, staffing, as well as billing and quality reporting. Reserved matters may be narrow, and board rights may not apply to day-to-day operations. Get the actual documents and map the decisions that matter to this group. Verbal assurances should be treated as discussion points until reflected in enforceable language.
Consider what happens if an owner leaves or is terminated. Does employment end the rollover rights, trigger a forced sale, change vesting, or alter distributions? Is the treatment different for voluntary departure, cause, disability, death, or retirement? Can an owner be required to sell at a formula price unrelated to the platform's value? Do restrictive covenants affect future professional work? These provisions can have substantial value even though they do not appear in the purchase price table.
Make a collective decision with independent advice
Each partner should understand the transaction's allocation, tax treatment, and obligations, differences driven by ownership percentage, employment status, or individual agreements. The group should identify conflicts where some owners receive different rollover amounts or have separate roles. Independent counsel can help each owner assess personal terms while transaction counsel coordinates shared issues. Tax and accounting advisers should review entity structure, proceeds timing, and rollover treatment. Advisers should be engaged early enough to influence the structure, not merely explain it after exclusivity begins.
Use a side-by-side comparison of offers that includes cash at close, escrow, note, earnout, rollover class, governance, employment, restrictive covenants, as well as indemnity and projected net proceeds under multiple scenarios. Record the assumptions and confidence level behind each item. Require the buyer to explain changes between drafts. If a material economic term moves, update the model and decision record instead of relying on the earlier headline number.
A sound evaluation ends with an explicit account of what is certain, what is contingent, what remains under physician control, and what the owners are betting on. The group may reasonably accept illiquidity in exchange for a chance to participate in platform growth. It should make that choice with a clear view of downside, time, as well as rights and personal obligations. The rollover is an investment decision that deserves the same care as a separate investment of comparable size.
Questions about your own practice? Contact richard@doctorsinvestorclub.com.
